Oxford Heart Centre, NIHR Biomedical Research Centre, Oxford University Hospitals, Headley Way, Oxford, OX39DU, UK.
Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy.
Int J Cardiovasc Imaging. 2021 Jun;37(6):1801-1813. doi: 10.1007/s10554-021-02254-8. Epub 2021 May 5.
To investigate the diagnostic accuracy of (1) hyperaemic angiography-derived index of microcirculatory resistance (IMR) in defining coronary microvascular dysfunction (CMD) across patients with acute coronary syndromes (ST-elevation myocardial infarction [STEMI]; non-ST elevation acute coronary syndrome [NSTE-ACS]) and stable chronic coronary syndrome [CCS]) and (2) the accuracy of non-hyperaemic IMR (NH-IMR) to detect CMD in STEMI. 145 patients (STEMI = 66; NSTEMI = 43; CCS = 36) were enrolled. 246 pressure-wire IMR measurements were made in 189 coronary vessels. IMR and NH-IMR was derived using quantitative flow ratio. In patients with STEMI, cardiac magnetic resonance was performed to quantify microvascular obstruction (MVO). IMR was correlated with IMR (overall rho = 0.78, p < 0.0001; STEMI, rho = 0.85 p < 0.0001; NSTE-ACS and rho = 0.72, p < 0.0001; CCS, rho = 0.70, p < 0.0001) and demonstrated good diagnostic performance in predicting high IMR (STEMI AUC = 0.93 [0.88-0.98]; NSTE-ACS AUC = 0.77 [0.63-0.92]; CCS AUC = 0.88 [0.79-0.97]). Agreement between the two indices was evident on Bland Altman analysis. In STEMI, NH-IMR was also well correlated with IMR (rho = 0.64, p < 0.0001), with good diagnostic accuracy in predicting high invasive IMR (AUC = 0.82 [0.74-0.90]). Both IMR (AUC = 0.74 [0.59-0.89]) and NH-IMR (AUC = 0.76 [0.54-0.87]) were significantly associated with MVO in STEMI. In conclusions, IMR is a valid alternative to invasive IMR to detect CMD in patients with acute and stable coronary syndromes, whilst NH-IMR has a good diagnostic accuracy in STEMI where it could become a user-friendly diagnostic tool as it is adenosine-free.
为了研究(1)在急性冠状动脉综合征(ST 段抬高型心肌梗死[STEMI];非 ST 段抬高型急性冠状动脉综合征[NSTE-ACS])和稳定型慢性冠状动脉综合征[CCS]患者中,基于充血状态的微血管阻力指数(IMR)对冠状动脉微血管功能障碍(CMD)的诊断准确性,以及(2)非充血状态 IMR(NH-IMR)检测 STEMI 中 CMD 的准确性,对 145 名患者(STEMI=66;NSTE-ACS=43;CCS=36)进行了研究。对 189 个冠状动脉进行了 246 次压力导丝 IMR 测量。使用定量血流比来推导 IMR 和 NH-IMR。在 STEMI 患者中,进行心脏磁共振成像以量化微血管阻塞(MVO)。IMR 与 IMR(整体 rho=0.78,p<0.0001;STEMI,rho=0.85,p<0.0001;NSTE-ACS,rho=0.72,p<0.0001;CCS,rho=0.70,p<0.0001)呈相关性,并在预测高 IMR 方面具有良好的诊断性能(STEMI AUC=0.93[0.88-0.98];NSTE-ACS AUC=0.77[0.63-0.92];CCS AUC=0.88[0.79-0.97])。 Bland Altman 分析显示两种指数之间具有良好的一致性。在 STEMI 中,NH-IMR 也与 IMR 高度相关(rho=0.64,p<0.0001),预测高侵入性 IMR 具有良好的诊断准确性(AUC=0.82[0.74-0.90])。在 STEMI 中,IMR(AUC=0.74[0.59-0.89])和 NH-IMR(AUC=0.76[0.54-0.87])均与 MVO 显著相关。总之,IMR 是一种替代有创性 IMR 检测急性和稳定型冠状动脉综合征患者 CMD 的有效方法,而 NH-IMR 在 STEMI 中具有良好的诊断准确性,它可以成为一种方便用户的诊断工具,因为它不含腺嘌呤。